This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Data Driven, Hybrid & Full Decentralized Clinical Trials
Mark Your Calendar for Data Driven, Hybrid and Full Decentralized Clinical Trials 2025!
In-Person Event: April 9 - 10, 2025Aloft Boston, Boston, MA

Jane Myles
Program Director at Decentralized Trial & Research Alliance (DTRA)


Jane has over 25 years of experience improving clinical trials and patient experiences. She has focused on driving innovation in trial design and execution to accelerate getting medicines to patients. Jane transitioned from molecule focus to portfolio focus about 13 years ago, first concentrating on patient recruitment, then patient experience and input, followed by adoption of patient-facing technology. In her current role as Program Director for the Decentralized Trials and Research Alliance (DTRA), she merges these focus areas. She also serves as Chairperson for Curebase’s Strategic Advisory Board, building DCT technology and services to increase trial access and inclusion. Additionally, she is a member of the Board of Directors of The Myositis Association, a patient.

Previously Jane was VP of Innovation at Curebase from 2021-2023, after having established processes and training to support the DCT COE at LabCorp (2020-2021).. Prior to that, she worked at Roche/Genentech for 17 years in various roles including operational program manager for hematology where she helped drive global implementation of patient-facing technology into trials. Jane has also held positions leading global trials at Lilly, Sanofi, small biotechs, and niche CROs. She’s a Canuck who loves San Francisco and the beach.

Agenda Sessions

  • Fireside Chat: Let’s Talk about Evidence - Sustaining DCT Adoption

  • Fireside Chat: Let’s Talk about Evidence - Sustaining DCT Adoption

  • Non-Profit Consortiums – Ongoing work to Involve Industry in Hybrid and Full Decentralised Trials